BCM
SZYM

Bayesian Capital Management’s SOLAZYME INC COM STK (DE) SZYM Stock Holding History

Bayesian Capital Management’s Portfolio SZYM Stock Details SZYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-21,100
Closed -$43K – 630
2016
Q1 		$43K Buy
+21,100
New +$37.6K 0.04% 333

Bayesian Capital Management's SZYM Position: Q2 2016 in Review

Bayesian Capital Management sold out of SOLAZYME INC COM STK (DE) (SZYM) in Q2 2016, closing a stake of 21,100 shares — an estimated $43K sold.

Bayesian Capital Management first reported a position in SZYM in Q1 2016 and held it in 1 quarter. The position peaked at $43K in Q1 2016. 0 funds tracked by Wall St. Rank hold SZYM as of Q2 2016.

  • Bayesian Capital Management reported no remaining SOLAZYME INC COM STK (DE) position as of Q2 2016 after selling out during the quarter.
  • Bayesian Capital Management sold 21,100 SOLAZYME INC COM STK (DE) shares in Q2 2016, an estimated $43K.
  • Bayesian Capital Management first reported a position in SOLAZYME INC COM STK (DE) in Q1 2016 and held it in 1 quarter.
  • Bayesian Capital Management's SOLAZYME INC COM STK (DE) position peaked at $43K in Q1 2016.
  • 0 funds tracked by Wall St. Rank held SOLAZYME INC COM STK (DE) as of Q2 2016.

Based on Bayesian Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.